http://www.moleculin.com
Moleculin Biotech, Inc. Company Intro
Moleculin Biotech is a clinical stage pharmaceutical company focused on the treatment of highly resistant cancers. These resistant cancers range from deadly brain tumors, to pancreatic cancer, acute myeloid leukemia, among others.
Industry
Healthcare
Moleculin Biotech, Inc. Headquaters
5300 Memorial Drive
Houston,77007
United States
Moleculin Biotech, Inc. Share price
17 May 2023 13:30 GMT
$0.6250
0.01 (1.44 %)
Moleculin Biotech, Inc. Market cap
$18.132 M
WMC RANKING
2023
Moleculin Biotech, Inc. # 318
BiotechnologyLatest Moleculin Biotech, Inc. News
29 Nov 2023
Moleculin Biotech (NASDAQ:MBRX) Research Coverage ...
About Moleculin Biotech ... Moleculin Biotech, Inc, a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of...
29 Nov 2023
Moleculin Biotech (NASDAQ:MBRX) Research Coverage ...
About Moleculin Biotech ... Moleculin Biotech, Inc, a clinical stage pharmaceutical company, focuses on the development of drug candidates for the treatment of...
29 Nov 2023
Moleculin Biotech (NASDAQ:MBRX) Research Coverage Started at StockNews.com
Read Moleculin Biotech (NASDAQ:MBRX) Research Coverage Started at StockNews.com at Defense World.
WMC Market Score
WMC Market to Revenue Score
Moleculin Biotech, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Moleculin Biotech, Inc. | USD | $0 | $20,768 | $-20,591 | $181M | 318 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Moleculin Biotech, Inc. Social Followers vs Top 4 Industry Competitors
Moleculin Biotech, Inc. Post vs Top 4 Industry Competitors
Moleculin Biotech, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Moleculin Biotech, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Moleculin Biotech, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Moleculin Biotech, Inc. | 0 | 36.29 | 0.02 | 0 | 0 | 0 | 15.66 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
